⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tlr3 agonist

Every month we try and update this database with for tlr3 agonist cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersNCT02643303
Head and Neck S...
Breast Cancer
Sarcoma
Merkel Cell Car...
Cutaneous T-Cel...
Melanoma
Renal Cancer
Bladder Cancer
Prostate Cancer
Testicular Canc...
Solid Tumor
Durvalumab
Tremelimumab
Poly-ICLC
18 Years - Ludwig Institute for Cancer Research
Pembrolizumab + Poly-ICLC in MRP Colon CancerNCT02834052
Metastatic Colo...
Solid Tumor
pembrolizumab
Poly-ICLC
18 Years - Augusta University
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersNCT02643303
Head and Neck S...
Breast Cancer
Sarcoma
Merkel Cell Car...
Cutaneous T-Cel...
Melanoma
Renal Cancer
Bladder Cancer
Prostate Cancer
Testicular Canc...
Solid Tumor
Durvalumab
Tremelimumab
Poly-ICLC
18 Years - Ludwig Institute for Cancer Research
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: